Koen Van Eygen

7PUBLICATIONS
38CO-AUTHORS
Haematological tumoursRegenerative medicine (incl. stem cells)Liquid biopsiesPacific Peoples cultural determinants of healthCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 18, 2026
Leveraging Digital Technology and Artificial Intelligence to Describe the Real-World Belgian Chronic Lymphocytic Leukemia Patient Population: The BE-CLLEAR Study.

Matthias Vanderkerken, Koen Van Eygen, Veerle Galle

|Jan 12, 2026
Modulation of the clonal burden in patients with lower-risk myelodysplastic neoplasms treated with imetelstat.

Valeria Santini, Amer M Zeidan, Koen Van Eygen

|Oct 17, 2024
Real-life data of luspatercept in lower-risk myelodysplastic syndromes advocate new research objectives.

Bert Heyrman, Stef Meers, Sélim Sid

|Jun 30, 2022
Acupuncture as a Complementary Therapy for Cancer Care: Acceptability and Preferences of Patients and Informal Caregivers.

Laura Tack, Tessa Lefebvre, Virginie Blieck

|Nov 19, 2021
Oncologic Home-Hospitalization Delivers a High-Quality and Patient-Centered Alternative to Standard Ambulatory Care: Results of a Randomized-Controlled Equivalence Trial.

Lieselot Cool, Jana Missiaen, Philip Debruyne

|Aug 02, 2021
Incidence of central nervous system relapses in patients with DLBCL treated with lenalidomide as maintenance after R-CHOP.

Sophie Bernard, Herve Ghesquieres, Rene-Olivier Casasnovas

Pageof 2

Frequent Collaborators

2 joint publications

Mrinal M Patnaik

2 joint publications

Uwe Platzbecker

2 joint publications

Hans Pottel

2 joint publications

Philip R Debruyne